FDA Clearance Tracker · K183513
XenoSure Dura Biologic Patch
Last checked: Nov 19, 2026Latest source record: Jun 13, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Jun 13, 2019
Substantially Equivalent
Time to decision
177 days
Received Dec 18, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K183513
- Device name
- XenoSure Dura Biologic Patch
- Applicant
- LeMaitre Vascular, Inc.
- Applicant location
- Burlington, MA
- Received
- Dec 18, 2018
- Decided
- Jun 13, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Dura Substitute (GXQ)
- Device class
- Class II
- Regulation
- 21 CFR 882.5910
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GXQ. The earliest in FDA's data is K950956, decided Jun 2, 1995.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K183513
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for LeMaitre Vascular, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PhasTIPP510(k)
K212894 · Decided Mar 31, 2022 · 202 days after receipt
Device type: Stripper, Vein, External (DWQ) · Cardiology
K173323 · Decided Mar 8, 2018 · 139 days after receipt
Device type: Clip, Implantable (FZP) · General & Plastic Surgery
K152833 · Decided Jan 21, 2016 · 114 days after receipt
Device type: Catheter, Intravascular Occluding, Temporary (MJN) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.